Plowright
Alleyn Plowright, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20090306133 | New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 - The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), | 12-10-2009 |
20100317653 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS - Compounds of formula (I), and salts and pro-drugs thereof: | 12-16-2010 |
Alleyn Plowright, Molndal SE
Patent application number | Description | Published |
---|---|---|
20100029727 | 1, 3, 4 -OXADIAZOLE DERIVATIVES AS DGAT1 INHIBITORS - Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 02-04-2010 |
Alleyn Thomas Plowright, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20090124682 | Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity - A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here—please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. | 05-14-2009 |
20110092547 | CHEMICAL COMPOUNDS 979 - Compounds of formula (I), or pharmaceutically-acceptable salts and/or pro-drugs thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 04-21-2011 |
20110152297 | QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS - The invention concerns quinazoline derivatives of the Formula I, or pharmaceutically acceptable salts thereof: | 06-23-2011 |
Alleyn Thomas Plowright, Molndal SE
Patent application number | Description | Published |
---|---|---|
20090197926 | BENZIMIDAZOLES AND THEIR USE FOR THE TREATMENT OF DIABETES - Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 08-06-2009 |
20090275620 | SUBSTITUTED 5- PHENYLAMINO- 1, 3, 4-OXADIAZOL-2-YLCARBONYLAMINO-4-PHENOXY-CYCLOHEXANE CARBOXYLIC ACID AS INHIBITORS OF ACETYL COENZYME A DIACYLGLYCEROL ACYLTRANSFERASE - Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 11-05-2009 |
20100173958 | COMPOUNDS FOR THE INHIBITION OF DGAT1 ACTIVITY - Compounds of formula (I), or salts thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 07-08-2010 |
Alleyn Thomas Plowright, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20100137397 | Chemical Compounds - A compound of the formula (1) or a pharmaceutically-acceptable salt: possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity such as 2 diabetes. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. | 06-03-2010 |